Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Latent membrane protein 2A (LMP-2A) is an Epstein-Barr virus (EBV) protein crucial for B lymphocyte survival and implicated in EBV-associated malignancies.
• LMP-2A modulates host cell signaling pathways through its N-terminal domain, interacting with cellular tyrosine kinases like Fyn and Lyn.
• The antigen recognition motif (ARAM) within LMP-2A is critical for kinase binding and signal transduction.

Purpose of the Study:

• To investigate the sequence variability of the LMP-2A N-terminal domain in natural EBV isolates.
• To determine if sequence variations affect critical functional motifs, particularly the ARAM.
• To assess the implications of LMP-2A polymorphisms for EBV infection and tumorigenesis.

Main Methods:

• Sequencing of the LMP-2A N-terminal domain from 28 EBV isolates, including 14 tumor-derived samples.
• Comparison of obtained sequences with the prototype B95 strain.
• Analysis of potential impacts of identified mutations on tyrosine protein kinase binding motifs and ARAM.

Main Results:

• LMP-2A sequence is generally conserved across EBV isolates, with minor amino acid changes in some.
• Five single-base loci in exon 1 of LMP-2A exhibit frequent mutations, forming three distinct polymorphic patterns.
• These prevalent polymorphisms, particularly at positions 79 and 82, do not affect key ARAM tyrosines/leucines but may alter interactions with cellular ligands.

Conclusions:

• Sequence variations in the LMP-2A N-terminal domain occur in natural EBV infections and are not specific to EBV types or tissue origins.
• While the core ARAM structure appears conserved, prevalent polymorphisms suggest potential modulation of LMP-2A's interaction with host cell proteins.
• These findings highlight the importance of LMP-2A sequence diversity in understanding EBV pathogenesis and associated diseases.